Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/14/2000 | US6147276 Quiescent cell populations for nuclear transfer in the production of non-human mammals and non-human mammalian embryos |
11/14/2000 | US6147202 Nucleotide sequences coding erythrocyte proteins; for utilization in blood transfusions |
11/14/2000 | US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents |
11/14/2000 | US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents |
11/14/2000 | US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression |
11/14/2000 | US6147050 5-lipoxygenase-activating protein II |
11/14/2000 | US6146903 Method for determination of water treatment polymers |
11/14/2000 | US6146891 Methods for cultivating cells and propagating viruses |
11/14/2000 | US6146890 Method and system for cultivating macrophages |
11/14/2000 | US6146889 Proliferation of hepatocyte precursors |
11/14/2000 | US6146888 Amplification of preferential cell population; mixing cells in which the genome codes an antibiotic resistance gene, recovering cells that propagate in the presence of antibiotic |
11/14/2000 | US6146885 Plasmid for transfer of genes into vertebrate cells |
11/14/2000 | US6146876 22025, a novel human cyclic nucleotide phosphodiesterase |
11/14/2000 | US6146875 Method for culturing microorganisms in prefilled flexible containers |
11/14/2000 | US6146868 Nucleotide and amino acid sequence of enzyme which deacetylates component of fungal capsule; fungicides for treatment of cryptococcosis |
11/14/2000 | US6146864 Nucleotide and amino acid sequence from fusarium venenatum; for recombinant production of enzyme |
11/14/2000 | US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase |
11/14/2000 | US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2) |
11/14/2000 | US6146841 Methods for identifying compounds that bind to CSAPK-3 molecules and fragments thereof |
11/14/2000 | US6146835 Nucleotide sequence; for drug screening of novel analgesics; for recombinant production of receptor |
11/14/2000 | US6146832 Protein kinase molecules and uses therefor |
11/14/2000 | US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects |
11/14/2000 | US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample |
11/14/2000 | US6146826 Green fluorescent protein |
11/14/2000 | US6146642 Recombinant new castle disease virus RNA expression systems and vaccines |
11/14/2000 | US6146634 Proteins with urease activity |
11/14/2000 | US6146627 Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody |
11/14/2000 | US6146623 A gene therapy for treating cancer |
11/14/2000 | CA2308892A1 Extender for the cryopreservation of bovine semen |
11/14/2000 | CA2074839C Modified factor vii anticoagulant proteins |
11/14/2000 | CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof |
11/10/2000 | CA2307446A1 Complex for transferring an anionic substance of interest into a cell |
11/09/2000 | WO2000066758A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
11/09/2000 | WO2000066755A2 Pesticidal fusions |
11/09/2000 | WO2000066754A1 Protein c derivatives |
11/09/2000 | WO2000066753A2 Modified vitamin k-dependent polypeptides |
11/09/2000 | WO2000066750A2 Methods for producing plants with elevated oleic acid content |
11/09/2000 | WO2000066748A1 Herbicide resistant plants |
11/09/2000 | WO2000066747A1 Herbicide resistant plants |
11/09/2000 | WO2000066746A1 Herbicide resistant plants |
11/09/2000 | WO2000066743A2 Viral expression vectors |
11/09/2000 | WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
11/09/2000 | WO2000066736A1 Growth factor homolog zvegf4 |
11/09/2000 | WO2000066735A2 Human ion channel proteins |
11/09/2000 | WO2000066732A2 Laminin 8 and methods for its use |
11/09/2000 | WO2000066731A2 Recombinant laminin 5 |
11/09/2000 | WO2000066730A2 Laminin 2 and methods for its use |
11/09/2000 | WO2000066726A1 Novel cellular regulation factor tto 20 |
11/09/2000 | WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
11/09/2000 | WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
11/09/2000 | WO2000066715A1 Method for diminishing specific immune reactions |
11/09/2000 | WO2000066714A2 Shiga-like toxin as an enriching and purging agent |
11/09/2000 | WO2000066713A2 Materials and methods relating to neuronal development |
11/09/2000 | WO2000066712A2 Modular cell carrier systems for the three-dimensional cell growth |
11/09/2000 | WO2000066709A2 Zymogen activation system |
11/09/2000 | WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
11/09/2000 | WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
11/09/2000 | WO2000066627A1 Expression of heparin-binding protein in recombinant mammalian cells |
11/09/2000 | WO2000066623A2 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
11/09/2000 | WO2000066188A2 Xenotransplant for cns therapy |
11/09/2000 | WO2000066178A1 Lim mineralization protein splice variants |
11/09/2000 | WO2000066177A1 GENE THERAPY USING TGF-$g(b) |
11/09/2000 | WO2000066158A2 Use of cytokines and mitogens to inhibit pathological immune responses |
11/09/2000 | WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
11/09/2000 | WO2000066155A1 Methods for preventing reactivation of latent virus and controlling virus replication |
11/09/2000 | WO2000066147A1 A method of inducing formation of kidney epithelia from mesenchymal precursors |
11/09/2000 | WO2000066145A1 Method for inducing the cell death of nerve cell line, method for screening compound inhibiting or promoting the cell death of nerve cells, and cell death inhibitor and promoter for nerve cells |
11/09/2000 | WO2000066137A1 Asialocytokines and treatment of liver disease |
11/09/2000 | WO2000066068A2 Method for inducing growth and enhancing survival of nervous tissue |
11/09/2000 | WO2000066036A2 Fabrication of vascularized tissue using microfabricated two-dimensional molds |
11/09/2000 | WO2000065908A1 Traf5 knockout mouse |
11/09/2000 | WO2000042195B1 Schizochytrium pks genes |
11/09/2000 | WO2000041713A3 Composition and method for improving function of embryonic kidney transplants |
11/09/2000 | WO2000040705A3 Human desaturase gene and uses thereof |
11/09/2000 | WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
11/09/2000 | WO2000039276A3 Microbial transformation method for the preparation of an epothilone |
11/09/2000 | WO2000037663A3 Plant transformation process |
11/09/2000 | WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth |
11/09/2000 | WO2000037607A3 Method for producing adipocytes from non-differentiated fibroblasts and use of resulting adipocytes |
11/09/2000 | WO2000036102A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/09/2000 | WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
11/09/2000 | WO2000034477A3 Neuron-associated proteins |
11/09/2000 | WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor |
11/09/2000 | WO2000034455A3 Methods and systems useful for transferring genes into pancreatic islets ex vivo and into the pancreas in vivo |
11/09/2000 | WO2000034454A3 Microcellular polymers as cell growth media and novel polymers |
11/09/2000 | WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
11/09/2000 | WO2000034443A3 Megakaryocyte-induced expansion of hematopoietic stem cells |
11/09/2000 | WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
11/09/2000 | WO2000032624A3 Uncoupling protein 5 - ucp5 |
11/09/2000 | WO2000031236A3 Vectors for gene mutagenesis and gene discovery by gene trapping |
11/09/2000 | WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon |
11/09/2000 | WO2000029564A3 Human glycine transporter type 2 |
11/09/2000 | WO2000029553A9 Bioengineered tissue constructs and methods for producing and using them |
11/09/2000 | WO2000028813A9 Treatment of myelogenous leukemia |
11/09/2000 | WO2000028034A3 Cytokine signal regulators |
11/09/2000 | WO2000027999A9 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
11/09/2000 | WO2000026381A3 High fidelity thermostable ligase and uses thereof |
11/09/2000 | WO2000026355A3 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
11/09/2000 | WO2000024780A3 Compositions and methods for treating polycystic kidney disease |
11/09/2000 | WO2000024771A3 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |